Il monitoraggio terapeutico dei farmaci è una branca della chimica clinica e della farmacologia clinica. Aiuta a misurare e mantenere una concentrazione uniforme del farmaco nel flusso sanguigno dei pazienti per ottenere risultati migliori. Il monitoraggio terapeutico dei farmaci fa parte della medicina personalizzata in cui è necessaria la misurazione della concentrazione del farmaco nel flusso sanguigno. Il monitoraggio dei farmaci terapeutici viene utilizzato fondamentalmente in caso di requisiti di concentrazioni di farmaci molto specifici.
DINAMICHE DEL MERCATO
Si prevede che il mercato del monitoraggio dei farmaci terapeutici crescerà nel periodo di previsione a causa di fattori trainanti quali la crescente domanda di trattamenti farmacologici personalizzati, i progressi nella ricerca sulla farmacogenomica e la farmacocinetica dei farmaci, la crescente prevalenza di malattie complesse come il cancro (artrite reumatoide, linfomi non Hodgkin), malattie respiratorie come l’apnea neonatale, l’asma polmonare, l’embolia e broncopneumopatia cronica ostruttiva (BPCO). I crescenti investimenti in infrastrutture di ricerca e sviluppo da parte di attori privati e governo guideranno il mercato del monitoraggio dei farmaci terapeutici nel prossimo futuro. Tuttavia, gli elevati costi infrastrutturali e la mancanza di professionisti qualificati rappresentano i limiti del mercato del monitoraggio terapeutico dei farmaci.
AMBITO DI MERCATO
L'analisi del mercato globale del monitoraggio terapeutico dei farmaci per 2031" è uno studio specializzato e approfondito del settore dei dispositivi medici con particolare attenzione all'analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato del monitoraggio dei farmaci terapeutici con una segmentazione dettagliata del mercato per prodotto, tecnologia, classe di farmaco, utente finale e area geografica. Si prevede che il mercato globale Monitoraggio terapeutico dei farmaci assisterà a una crescita elevata durante il periodo di previsione. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato Monitoraggio terapeutico dei farmaci e offre tendenze e opportunità chiave nel mercato.
SEGMENTAZIONE DEL MERCATO
Il globale Il mercato del monitoraggio dei farmaci terapeutici è segmentato in base al prodotto, alla tecnologia, alla classe del farmaco e all’utente finale. In base al prodotto, il mercato è segmentato in Attrezzature e materiali di consumo. Sulla base della tecnologia, il mercato globale del monitoraggio dei farmaci terapeutici è segmentato in test immunologici, cromatografia-Ms, test radioimmunologici e altri. Per classe di farmaci, il mercato è segmentato in farmaci antibiotici, farmaci antiepilettici, farmaci antiaritmici, farmaci broncodilatatori, farmaci immunosoppressori, farmaci psicoattivi, farmaci antitumorali e altri farmaci. In base all'utente finale, il mercato globale del monitoraggio terapeutico dei farmaci è suddiviso in laboratori ospedalieri, laboratori privati e altri laboratori.
< /strong>
Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato globale del monitoraggio dei farmaci terapeutici in base a vari segmenti. Fornisce inoltre stime sulle dimensioni del mercato e sulle previsioni dall’anno 2021 al 2031 rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud & America Centrale. Il mercato del monitoraggio dei farmaci terapeutici per ciascuna regione è successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l'analisi e le previsioni di 18 paesi a livello globale insieme alle tendenze attuali e alle opportunità prevalenti nella regione.
Il rapporto analizza i fattori che influenzano il mercato del monitoraggio terapeutico dei farmaci sia dal lato della domanda che dell'offerta e oltre valuta le dinamiche di mercato che influiscono sul mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud & America Centrale dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato del monitoraggio terapeutico dei farmaci in queste regioni.
ATTORI DI MERCATO
I rapporti coprono gli sviluppi chiave nel mercato del monitoraggio dei farmaci terapeutici come strategie di crescita organica e inorganica. Diverse aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altri come brevetti ed eventi. Le attività delle strategie di crescita inorganica testimoniate nel mercato sono state acquisizioni e partnership & collaborazioni. Queste attività hanno aperto la strada all’espansione del business e della base clienti degli operatori del mercato. Si prevede che gli attori del mercato del monitoraggio terapeutico dei farmaci avranno opportunità di crescita redditizie in futuro con la crescente domanda di monitoraggio terapeutico dei farmaci nel mercato globale. Di seguito è riportato l'elenco di alcune aziende impegnate nel mercato del monitoraggio terapeutico dei farmaci.
Il rapporto include anche i profili delle principali società di mercato del monitoraggio dei farmaci terapeutici insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni, sviluppi chiave negli ultimi cinque anni.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- Bühlmann Laboratories AG
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Randox Laboratories Ltd.
- Sekisui Medical Co. Ltd.
- Siemens Healthineers
- Thermo Fisher Scientific
- li>
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Analog-to-Digital Converter Market
- EMC Testing Market
- Cling Films Market
- Foot Orthotic Insoles Market
- Queue Management System Market
- Semiconductor Metrology and Inspection Market
- Hydrolyzed Collagen Market
- Bioremediation Technology and Services Market
- Carbon Fiber Market
- Mobile Phone Insurance Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Consumables segment, by product, dominated the market in 2023.
Players operating in the market are Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, bioMerieux SA, Bühlmann Laboratories AG, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Randox Laboratories Ltd.
North America region dominated the Therapeutic Drug Monitoring market in 2023.
Point-of-Care Testing act as a opportunity for growth of the market in forecast period.
The Therapeutic Drug Monitoring Market is estimated to witness a CAGR of 9.0% from 2023 to 2031
The major factors driving the Therapeutic Drug Monitoring market are:
1. Rising Prevalence of Chronic Diseases.
2.Growth in Personalized Medicine
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Abbott Laboratories
2. Agilent Technologies, Inc.
3. Bio-Rad Laboratories Inc.
4. bioMerieux SA
5. Bühlmann Laboratories AG
6. Danaher Corporation
7. F. Hoffmann-La Roche Ltd
8. Randox Laboratories Ltd.
9. Siemens Healthineers
10. Thermo Fisher Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For